The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis -- 2

dc.contributor.authorCan, Güray
dc.contributor.authorAyvaz, Süleyman
dc.contributor.authorCan, Hatice
dc.contributor.authorKaraboğa, İhsan
dc.contributor.authorDemirtaş, Selim
dc.contributor.authorAkşit, Hasan
dc.contributor.authorYılmaz, Bülent
dc.date.accessioned2020-03-26T19:31:41Z
dc.date.available2020-03-26T19:31:41Z
dc.date.issued2016
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.endpageS127en_US
dc.identifier.issn1873-9946en_US
dc.identifier.issn1876-4479en_US
dc.identifier.startpageS126en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/34092
dc.identifier.volume10en_US
dc.identifier.wosWOS:000374496600198en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOXFORD UNIV PRESSen_US
dc.relation.ispartofJOURNAL OF CROHNS & COLITISen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleThe efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis -- 2en_US
dc.typeConference Objecten_US

Dosyalar